These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
3. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease. Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096 [TBL] [Abstract][Full Text] [Related]
4. Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β. Amin J; Paquet C; Baker A; Asuni AA; Love S; Holmes C; Hugon J; Nicoll JA; Boche D Neuropathol Appl Neurobiol; 2015 Jun; 41(4):445-57. PubMed ID: 25486988 [TBL] [Abstract][Full Text] [Related]
5. Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3β. Kawakami F; Suzuki M; Shimada N; Kagiya G; Ohta E; Tamura K; Maruyama H; Ichikawa T FEBS J; 2011 Dec; 278(24):4895-904. PubMed ID: 21985244 [TBL] [Abstract][Full Text] [Related]
6. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells. Wu X; Kosaraju J; Tam KY Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686 [TBL] [Abstract][Full Text] [Related]
7. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model. Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy. Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668 [TBL] [Abstract][Full Text] [Related]
9. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor. Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749 [TBL] [Abstract][Full Text] [Related]
10. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. Liu F; Iqbal K; Grundke-Iqbal I; Gong CX FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894 [TBL] [Abstract][Full Text] [Related]
11. Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. Hernández F; Borrell J; Guaza C; Avila J; Lucas JJ J Neurochem; 2002 Dec; 83(6):1529-33. PubMed ID: 12472906 [TBL] [Abstract][Full Text] [Related]
12. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease. Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602 [TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link. Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110 [TBL] [Abstract][Full Text] [Related]
14. Ferroptosis promotes microtubule-associated protein tau aggregation via GSK-3β activation and proteasome inhibition. Wang S; Jiang Y; Liu Y; Liu Q; Sun H; Mei M; Liao X Mol Neurobiol; 2022 Mar; 59(3):1486-1501. PubMed ID: 34997541 [TBL] [Abstract][Full Text] [Related]
15. NAP Protects against Tau Hyperphosphorylation Through GSK3. Ivashko-Pachima Y; Gozes I Curr Pharm Des; 2018; 24(33):3868-3877. PubMed ID: 30417779 [TBL] [Abstract][Full Text] [Related]
16. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation. Elyaman W; Terro F; Wong NS; Hugon J Eur J Neurosci; 2002 Feb; 15(4):651-60. PubMed ID: 11886446 [TBL] [Abstract][Full Text] [Related]
17. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro. Fu ZQ; Yang Y; Song J; Jiang Q; Lin ZC; Wang Q; Zhu LQ; Wang JZ; Tian Q J Alzheimers Dis; 2010; 21(4):1107-17. PubMed ID: 21504119 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation. Zhang YJ; Xu YF; Liu YH; Yin J; Wang JZ FEBS Lett; 2005 Nov; 579(27):6230-6. PubMed ID: 16253246 [TBL] [Abstract][Full Text] [Related]
19. TPPU protects tau from H Yao ES; Tang Y; Liu XH; Wang MH J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):785-790. PubMed ID: 27924507 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells. Ishii T; Furuoka H; Muroi Y; Nishimura M J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]